Fundraising Fox

Mitralign

Tewksbury, US · Delaware corporation · 3 known investors

Healthtech

Founders & leadership

LM
Lisa MastromatteiExecutive
LW
Lisa Wipperman HeineExecutive
SW
Sophia WongExecutive
RP
Richard P. GeoffrionNamed on SEC filing

Board

MV
Martien Van OschBoard director
DC
Daniel ColeBoard director
CB
Carolyn BatesBoard director
AP
Aditya PuriBoard director
YB
Yuval BinurBoard director
ZZ
Zi ZhenjunBoard director
DL
Daniel LemaitreBoard director

Investors · 3

415 CapitalMunich · $5.4M – $16.2M
Qiming Venture PartnersBeijing · $5M – $134M
Oxford Bioscience Partnersreported

Reported raises · per SEC filings

Form D private placements

$17.8M disclosed across 2 rounds · 2014–2017

▶$9.8MraisedFeb 2018 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lisa MastromatteiExecutive Officer
  • Martien Van OschDirector
  • Daniel ColeDirector
  • Carolyn BatesDirector
  • Lisa Wipperman HeineExecutive Officer
  • Richard P. GeoffrionExecutive Officer, Director
  • Aditya PuriDirector
  • Yuval BinurDirector
Offering amount
$30.2M
Amount sold
$9.8M
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.1MraisedJun 2014 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Sophia WongExecutive Officer
  • Richard P. GeoffrionExecutive Officer, Director
  • Yuval BinurExecutive Officer, Director
  • Daniel LemaitreDirector
  • Carolyn BatesDirector
  • Martien Van OschDirector
  • Daniel ColeDirector
  • Zi ZhenjunDirector
Amount sold
$8.1M
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Mitralign raises almost US$40 million in equity financing - Cardiovascular Newscardiovascularnews.com · May 2016Massachusetts' Mitralign Raises $40 Million for Heart Valve Repair Devices - BioSpacebiospace.com · May 2016Tricuspid, mitral valve repair startup raises $40M to back regulatory approvals, launch | Fierce Biotechfiercebiotech.com · May 2016Mitralign raises another $8M - MassDevicemassdevice.com · Jun 2014Mitralign, Inc. Raises $35 Million Series D Financing - BioSpacebiospace.com · May 2012Mitralign reports 1st-in-human tricuspid valve repair - MassDevicemassdevice.com

Frequently asked questions

Who are Mitralign's investors?
Mitralign's investors include 415 Capital, Qiming Venture Partners, Oxford Bioscience Partners.
How much funding has Mitralign raised?
Mitralign has disclosed $17.8M raised across 2 rounds.
Where is Mitralign headquartered?
Mitralign is headquartered in Tewksbury, US.